2030年までの欧州ライフサイエンス・分析機器市場調査予測Europe Life Science & Analytical Instruments Market Research Forecast to 2030 欧州のライフサイエンス・分析機器市場の2030年までの予測 市場概要 欧州のライフサイエンス・分析機器市場の成長は、さまざまな分野での分析機器需要の高まり、ライフサイエンス・分析機器市場における戦略的... もっと見る
サマリー欧州のライフサイエンス・分析機器市場の2030年までの予測市場概要 欧州のライフサイエンス・分析機器市場の成長は、さまざまな分野での分析機器需要の高まり、ライフサイエンス・分析機器市場における戦略的イニシアチブの増加、院内感染(HAI)の流行拡大、未開拓の新興国などに起因している。しかし、熟練した専門家が少ないことが市場成長の妨げになると予想されている。 生命科学とは、生物の物理的・化学的構造、機能、発生、進化、生態を含む科学的研究である。ライフサイエンス分析装置は、病院、診断研究所、製薬会社などで使用されている。さらに、これらの機器は、医薬品開発に使用される材料の成分、含有量、品質の評価など、さまざまな目的に利用することができます。 生命科学とは、生物の物理的・化学的構造、機能、発生、進化、生態などを科学的に研究する学問である。ライフサイエンス分析装置は、病院、診断研究所、製薬会社などで使用されている。さらに、これらの機器は、医薬品開発に使用される材料の成分、含有量、品質の評価など、さまざまな目的に利用することができる。 市場区分 タイプ別に見ると、欧州のライフサイエンス&分析機器市場は、顕微鏡、クロマトグラフィー、細胞計数、分光学、PCR、電気泳動、フローサイトメトリー、次世代シーケンシング、遠心分離機、低温機器、その他に分けられる。 用途別では、欧州のライフサイエンス&分析機器市場は臨床・診断用途、研究用途、その他に分類される。 エンドユーザー別では、欧州ライフサイエンス・分析機器市場は製薬・バイオテクノロジー企業、病院・診断研究所、その他に分類される。 地域分析 欧州地域におけるバイオ医薬品セクターの活性化、増加する慢性疾患の治療法を見つけるための研究を推進する政府のイニシアティブの高まり、製薬メーカーの増加、経済の改善、一人当たりの可処分所得の高さ、医療支出の増加などの要因が、同地域の市場成長を促進している。さらに、研究開発活動の活発化とバイオ医薬品分野の発展も、欧州市場を牽引すると予想される。ドイツのような国々ではハイエンド技術が利用可能であり、先進的な研究を実施するために様々な公的機関や民間からの資金援助が増加していることが、市場の成長を促進している。欧州を拠点とする企業も、積極的な提携やM&Aによって市場を後押ししている。 主要企業 サーモフィッシャーサイエンティフィック社、メルクKGAA、BD社、アジレント・テクノロジー社、パーキンエルマー社 目次TABLE OF CONTENTS1 EXECUTIVE SUMMARY 12 1.1 OVERVIEW 12 2 MARKET INTRODUCTION 13 2.1 DEFINITION 13 2.2 SCOPE OF THE STUDY 13 2.3 RESEARCH OBJECTIVE 13 2.4 MARKET STRUCTURE 14 2.5 ASSUMPTIONS & LIMITATIONS 14 3 RESEARCH METHODOLOGY 15 3.1 DATA MINING 15 3.2 SECONDARY RESEARCH 16 3.3 PRIMARY RESEARCH 17 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 18 3.5 FORECASTING TECHNIQUES 19 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20 3.6.1 BOTTOM-UP APPROACH 21 3.6.2 TOP-DOWN APPROACH 21 3.7 DATA TRIANGULATION 22 3.8 VALIDATION 22 4 MARKET DYNAMICS 23 4.1 OVERVIEW 23 4.2 DRIVERS 24 4.2.1 RISING DEMAND FOR ANALYTICAL INSTRUMENTS IN DIFFERENT SECTORS 24 4.2.2 INCREASING STRATEGIC INITIATIVES IN THE LIFE SCIENCE AND ANALYTICAL INSTRUMENTS MARKET 24 4.2.3 GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS (HAIS) 25 4.3 RESTRAINTS 26 4.3.1 DEARTH OF SKILLED PROFESSIONALS 26 4.4 OPPORTUNITIES 27 4.4.1 UNTAPPED EMERGING ECONOMIES 27 5 MARKET FACTOR ANALYSIS 28 5.1 VALUE CHAIN ANALYSIS 28 5.1.1 R&D 29 5.1.2 MANUFACTURING 29 5.1.3 DISTRIBUTION & SALES 29 5.1.4 POST-SALES MONITORING 29 5.2 PORTER'S FIVE FORCES MODEL 30 5.2.1 THREAT OF NEW ENTRANTS 30 5.2.2 BARGAINING POWER OF SUPPLIERS 30 5.2.3 THREAT OF SUBSTITUTES 31 5.2.4 BARGAINING POWER OF BUYERS 31 5.2.5 INTENSITY OF RIVALRY 31 5.3 IMPACT OF COVID-19 ON THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 31 5.3.1 IMPACT ON SUPPLY CHAIN 31 5.3.2 IMPACT ON PRODUCTION 32 5.3.3 IMPACT ON MARKET PLAYERS 32 5.4 QUALITATIVE ANALYSIS OF CGT AND RNA TECHNOLOGIES IN GERMANY 32 5.4.1 OVERVIEW 32 5.4.2 INCREASING INVESTMENTS THROUGH PUBLIC AND PRIVATE SECTORS 32 5.4.3 EMERGING CGT AND RNA TECHNOLOGIES 33 6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE 34 6.1 OVERVIEW 34 6.2 SPECTROSCOPY 35 6.3 CHROMATOGRAPHY 36 6.4 PCR 37 6.5 MICROSCOPY 38 6.6 FLOW CYTOMETRY 39 6.7 NEXT GENERATION SEQUENCING 39 6.8 CENTRIFUGES 40 6.9 ELECTROPHORESIS 41 6.10 CELL COUNTING 41 6.11 CRYOGENIC INSTRUMENTS 42 6.12 OTHERS 43 7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION 44 7.1 OVERVIEW 44 7.2 RESEARCH APPLICATIONS 45 7.3 CLINICAL & DIAGNOSTIC APPLICATIONS 45 7.4 OTHERS 46 8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER 47 8.1 OVERVIEW 47 8.2 HOSPITALS AND DIAGNOSTIC LABORATORIES 48 8.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 48 8.4 OTHERS 49 9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY 51 9.1 EUROPE 51 9.2 GERMANY 54 9.3 FRANCE 56 9.4 UK 57 9.5 ITALY 59 9.6 SWITZERLAND 60 9.7 SPAIN 62 9.8 REST OF EUROPE 63 10 COMPETITIVE LANDSCAPE 65 10.1 OVERVIEW 65 10.2 COMPETITIVE BENCHMARKING 66 10.3 MAJOR GROWTH STRATEGY IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67 10.5 KEY DEVELOPMENT ANALYSIS 68 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 68 10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL 68 10.6.2 MERGER /ACQUISTION 68 10.7 FINANCIAL MATRIX 69 10.7.1 SALES (USD MILLION), 2021 69 10.7.2 R&D EXPENDITURE (USD MILLION), 2021 69 11 COMPANY PROFILES 70 11.1 THERMO FISHER SCIENTIFIC INC. 70 11.1.1 COMPANY OVERVIEW 70 11.1.2 FINANCIAL OVERVIEW 71 11.1.3 PRODUCTS OFFERED 72 11.1.4 KEY DEVELOPMENTS 72 11.1.5 SWOT ANALYSIS 73 11.1.6 KEY STRATEGIES 73 11.2 AGILENT TECHNOLOGIES INC. 74 11.2.1 COMPANY OVERVIEW 74 11.2.2 FINANCIAL OVERVIEW 75 11.2.3 PRODUCTS OFFERED 76 11.2.4 KEY DEVELOPMENTS 76 11.2.5 KEY STRATEGIES 76 11.3 QIAGEN 77 11.3.1 COMPANY OVERVIEW 77 11.3.2 FINANCIAL OVERVIEW 78 11.3.3 PRODUCTS OFFERED 78 11.3.4 KEY DEVELOPMENTS 79 11.3.5 SWOT ANALYSIS 79 11.3.6 KEY STRATEGIES 79 11.4 PERKINELMER INC. 80 11.4.1 COMPANY OVERVIEWS 80 11.4.2 FINANCIAL OVERVIEW 80 11.4.3 PRODUCTS OFFERED 81 11.4.4 KEY DEVELOPMENTS 81 11.4.5 KEY STRATEGIES 81 11.5 MERCK KGAA 82 11.5.1 COMPANY OVERVIEW 82 11.5.2 FINANCIAL OVERVIEW 83 11.5.3 PRODUCTS OFFERED 83 11.5.4 KEY DEVELOPMENTS 84 11.5.5 SWOT ANALYSIS 85 11.5.6 KEY STRATEGIES 85 11.6 EPPENDORF SE 86 11.6.1 COMPANY OVERVIEWS 86 11.6.2 FINANCIAL OVERVIEW 87 11.6.3 PRODUCTS OFFERED 88 11.6.4 KEY DEVELOPMENTS 88 11.6.5 KEY STRATEGIES 88 11.7 BRUKER 89 11.7.1 COMPANY OVERVIEW 89 11.7.2 FINANCIAL OVERVIEW 90 11.7.3 PRODUCTS OFFERED 91 11.7.4 KEY DEVELOPMENTS 92 11.7.5 SWOT ANALYSIS 92 11.7.6 KEY STRATEGIES 93 11.8 BD. 94 11.8.1 COMPANY OVERVIEW 94 11.8.2 FINANCIAL OVERVIEW 95 11.8.3 PRODUCTS OFFERED 95 11.8.4 KEY DEVELOPMENTS 96 11.8.5 KEY STRATEGIES 96 11.9 BIO-RAD LABORATORIES, INC. 97 11.9.1 COMPANY OVERVIEW 97 11.9.2 FINANCIAL OVERVIEW 98 11.9.3 PRODUCTS OFFERED 98 11.9.4 KEY DEVELOPMENTS 99 11.9.5 KEY STRATEGIES 99 11.10 HITACHI HIGH-TECHNOLOGIES CORPORATION 100 11.10.1 COMPANY OVERVIEW 100 11.10.2 FINANCIAL OVERVIEW 100 11.10.3 PRODUCTS OFFERED 101 11.10.4 KEY DEVELOPMENTS 101 11.10.5 SWOT ANALYSIS 102 11.10.6 KEY STRATEGIES 102 12 APPENDIX 103 12.1 REFERENCES 103 12.2 RELATED REPORTS 103 ? 図表リストLIST OF TABLESTABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14 TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 17 TABLE 3 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 35 TABLE 4 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR SPECTROSCOPY, BY COUNTRY, 2018?2030 (USD MILLION) 36 TABLE 5 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CHROMATOGRAPHY, BY COUNTRY, 2018?2030 (USD MILLION) 37 TABLE 6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PCR, BY COUNTRY, 2018?2030 (USD MILLION) 38 TABLE 7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR MICROSCOPY, BY COUNTRY, 2018?2030 (USD MILLION) 38 TABLE 8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR FLOW CYTOMETRY, BY COUNTRY, 2018?2030 (USD MILLION) 39 TABLE 9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR NEXT GENERATION SEQUENCING, BY COUNTRY, 2018?2030 (USD MILLION) 40 TABLE 10 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CENTRIFUGES, BY COUNTRY, 2018?2030 (USD MILLION) 40 TABLE 11 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR ELECTROPHORESIS, BY COUNTRY, 2018?2030 (USD MILLION) 41 TABLE 12 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CELL COUNTING, BY COUNTRY, 2018?2030 (USD MILLION) 42 TABLE 13 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CRYOGENIC INSTRUMENTS, BY COUNTRY, 2018?2030 (USD MILLION) 42 TABLE 14 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 43 TABLE 15 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 44 TABLE 16 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018?2030 (USD MILLION) 45 TABLE 17 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CLINICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018?2030 (USD MILLION) 46 TABLE 18 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 46 TABLE 19 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 47 TABLE 20 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018?2030 (USD MILLION) 48 TABLE 21 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018?2030 (USD MILLION) 49 TABLE 22 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 50 TABLE 23 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2018?2030 (USD MILLION) 52 TABLE 24 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 53 TABLE 25 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 53 TABLE 26 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 54 TABLE 27 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 54 TABLE 28 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 55 TABLE 29 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 55 TABLE 30 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 56 TABLE 31 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 56 TABLE 32 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 57 TABLE 33 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 57 TABLE 34 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 58 TABLE 35 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 58 TABLE 36 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 59 TABLE 37 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 59 TABLE 38 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 60 TABLE 39 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 60 TABLE 40 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 61 TABLE 41 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 61 TABLE 42 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 62 TABLE 43 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 62 TABLE 44 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 63 TABLE 45 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 63 TABLE 46 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 64 TABLE 47 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 64 TABLE 48 MAJOR PLAYERS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 65 TABLE 49 MOST ACTIVE PLAYER IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67 TABLE 50 PRODUCT LAUNCH/ PRODUCT APPROVAL 68 TABLE 51 MERGER/ACQUISITION 68 TABLE 52 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 72 TABLE 53 AGILENT TECHNOLOGIES: PRODUCTS OFFERED 76 TABLE 54 QIAGEN: PRODUCTS OFFERED 78 TABLE 55 QIAGEN: KEY DEVELOPMENTS 79 TABLE 56 PERKINELMER INC.: PRODUCTS OFFERED 81 TABLE 57 MERCK KGAA: PRODUCTS OFFERED 83 TABLE 58 MERCK KGAA: KEY DEVELOPMENTS 84 TABLE 59 EPPENDORF SE: PRODUCTS OFFERED 88 TABLE 60 BRUKER: PRODUCTS OFFERED 91 TABLE 61 BRUKER: KEY DEVELOPMENTS 92 TABLE 62 BD.: PRODUCTS OFFERED 95 TABLE 63 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 98 TABLE 64 HITACHI HIGH-TECHNOLOGIES CORPORATION: PRODUCTS OFFERED 101 ?
SummaryEurope Life Science & Analytical Instruments Market Research Forecast to 2030 Table of ContentsTABLE OF CONTENTS1 EXECUTIVE SUMMARY 12 1.1 OVERVIEW 12 2 MARKET INTRODUCTION 13 2.1 DEFINITION 13 2.2 SCOPE OF THE STUDY 13 2.3 RESEARCH OBJECTIVE 13 2.4 MARKET STRUCTURE 14 2.5 ASSUMPTIONS & LIMITATIONS 14 3 RESEARCH METHODOLOGY 15 3.1 DATA MINING 15 3.2 SECONDARY RESEARCH 16 3.3 PRIMARY RESEARCH 17 3.4 BREAKDOWN OF PRIMARY RESPONDENTS 18 3.5 FORECASTING TECHNIQUES 19 3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 20 3.6.1 BOTTOM-UP APPROACH 21 3.6.2 TOP-DOWN APPROACH 21 3.7 DATA TRIANGULATION 22 3.8 VALIDATION 22 4 MARKET DYNAMICS 23 4.1 OVERVIEW 23 4.2 DRIVERS 24 4.2.1 RISING DEMAND FOR ANALYTICAL INSTRUMENTS IN DIFFERENT SECTORS 24 4.2.2 INCREASING STRATEGIC INITIATIVES IN THE LIFE SCIENCE AND ANALYTICAL INSTRUMENTS MARKET 24 4.2.3 GROWING PREVALENCE OF HOSPITAL-ACQUIRED INFECTIONS (HAIS) 25 4.3 RESTRAINTS 26 4.3.1 DEARTH OF SKILLED PROFESSIONALS 26 4.4 OPPORTUNITIES 27 4.4.1 UNTAPPED EMERGING ECONOMIES 27 5 MARKET FACTOR ANALYSIS 28 5.1 VALUE CHAIN ANALYSIS 28 5.1.1 R&D 29 5.1.2 MANUFACTURING 29 5.1.3 DISTRIBUTION & SALES 29 5.1.4 POST-SALES MONITORING 29 5.2 PORTER'S FIVE FORCES MODEL 30 5.2.1 THREAT OF NEW ENTRANTS 30 5.2.2 BARGAINING POWER OF SUPPLIERS 30 5.2.3 THREAT OF SUBSTITUTES 31 5.2.4 BARGAINING POWER OF BUYERS 31 5.2.5 INTENSITY OF RIVALRY 31 5.3 IMPACT OF COVID-19 ON THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 31 5.3.1 IMPACT ON SUPPLY CHAIN 31 5.3.2 IMPACT ON PRODUCTION 32 5.3.3 IMPACT ON MARKET PLAYERS 32 5.4 QUALITATIVE ANALYSIS OF CGT AND RNA TECHNOLOGIES IN GERMANY 32 5.4.1 OVERVIEW 32 5.4.2 INCREASING INVESTMENTS THROUGH PUBLIC AND PRIVATE SECTORS 32 5.4.3 EMERGING CGT AND RNA TECHNOLOGIES 33 6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE 34 6.1 OVERVIEW 34 6.2 SPECTROSCOPY 35 6.3 CHROMATOGRAPHY 36 6.4 PCR 37 6.5 MICROSCOPY 38 6.6 FLOW CYTOMETRY 39 6.7 NEXT GENERATION SEQUENCING 39 6.8 CENTRIFUGES 40 6.9 ELECTROPHORESIS 41 6.10 CELL COUNTING 41 6.11 CRYOGENIC INSTRUMENTS 42 6.12 OTHERS 43 7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION 44 7.1 OVERVIEW 44 7.2 RESEARCH APPLICATIONS 45 7.3 CLINICAL & DIAGNOSTIC APPLICATIONS 45 7.4 OTHERS 46 8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER 47 8.1 OVERVIEW 47 8.2 HOSPITALS AND DIAGNOSTIC LABORATORIES 48 8.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 48 8.4 OTHERS 49 9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY 51 9.1 EUROPE 51 9.2 GERMANY 54 9.3 FRANCE 56 9.4 UK 57 9.5 ITALY 59 9.6 SWITZERLAND 60 9.7 SPAIN 62 9.8 REST OF EUROPE 63 10 COMPETITIVE LANDSCAPE 65 10.1 OVERVIEW 65 10.2 COMPETITIVE BENCHMARKING 66 10.3 MAJOR GROWTH STRATEGY IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67 10.5 KEY DEVELOPMENT ANALYSIS 68 10.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 68 10.6.1 PRODUCT LAUNCH/ PRODUCT APPROVAL 68 10.6.2 MERGER /ACQUISTION 68 10.7 FINANCIAL MATRIX 69 10.7.1 SALES (USD MILLION), 2021 69 10.7.2 R&D EXPENDITURE (USD MILLION), 2021 69 11 COMPANY PROFILES 70 11.1 THERMO FISHER SCIENTIFIC INC. 70 11.1.1 COMPANY OVERVIEW 70 11.1.2 FINANCIAL OVERVIEW 71 11.1.3 PRODUCTS OFFERED 72 11.1.4 KEY DEVELOPMENTS 72 11.1.5 SWOT ANALYSIS 73 11.1.6 KEY STRATEGIES 73 11.2 AGILENT TECHNOLOGIES INC. 74 11.2.1 COMPANY OVERVIEW 74 11.2.2 FINANCIAL OVERVIEW 75 11.2.3 PRODUCTS OFFERED 76 11.2.4 KEY DEVELOPMENTS 76 11.2.5 KEY STRATEGIES 76 11.3 QIAGEN 77 11.3.1 COMPANY OVERVIEW 77 11.3.2 FINANCIAL OVERVIEW 78 11.3.3 PRODUCTS OFFERED 78 11.3.4 KEY DEVELOPMENTS 79 11.3.5 SWOT ANALYSIS 79 11.3.6 KEY STRATEGIES 79 11.4 PERKINELMER INC. 80 11.4.1 COMPANY OVERVIEWS 80 11.4.2 FINANCIAL OVERVIEW 80 11.4.3 PRODUCTS OFFERED 81 11.4.4 KEY DEVELOPMENTS 81 11.4.5 KEY STRATEGIES 81 11.5 MERCK KGAA 82 11.5.1 COMPANY OVERVIEW 82 11.5.2 FINANCIAL OVERVIEW 83 11.5.3 PRODUCTS OFFERED 83 11.5.4 KEY DEVELOPMENTS 84 11.5.5 SWOT ANALYSIS 85 11.5.6 KEY STRATEGIES 85 11.6 EPPENDORF SE 86 11.6.1 COMPANY OVERVIEWS 86 11.6.2 FINANCIAL OVERVIEW 87 11.6.3 PRODUCTS OFFERED 88 11.6.4 KEY DEVELOPMENTS 88 11.6.5 KEY STRATEGIES 88 11.7 BRUKER 89 11.7.1 COMPANY OVERVIEW 89 11.7.2 FINANCIAL OVERVIEW 90 11.7.3 PRODUCTS OFFERED 91 11.7.4 KEY DEVELOPMENTS 92 11.7.5 SWOT ANALYSIS 92 11.7.6 KEY STRATEGIES 93 11.8 BD. 94 11.8.1 COMPANY OVERVIEW 94 11.8.2 FINANCIAL OVERVIEW 95 11.8.3 PRODUCTS OFFERED 95 11.8.4 KEY DEVELOPMENTS 96 11.8.5 KEY STRATEGIES 96 11.9 BIO-RAD LABORATORIES, INC. 97 11.9.1 COMPANY OVERVIEW 97 11.9.2 FINANCIAL OVERVIEW 98 11.9.3 PRODUCTS OFFERED 98 11.9.4 KEY DEVELOPMENTS 99 11.9.5 KEY STRATEGIES 99 11.10 HITACHI HIGH-TECHNOLOGIES CORPORATION 100 11.10.1 COMPANY OVERVIEW 100 11.10.2 FINANCIAL OVERVIEW 100 11.10.3 PRODUCTS OFFERED 101 11.10.4 KEY DEVELOPMENTS 101 11.10.5 SWOT ANALYSIS 102 11.10.6 KEY STRATEGIES 102 12 APPENDIX 103 12.1 REFERENCES 103 12.2 RELATED REPORTS 103 ? List of Tables/GraphsLIST OF TABLESTABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 14 TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 17 TABLE 3 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 35 TABLE 4 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR SPECTROSCOPY, BY COUNTRY, 2018?2030 (USD MILLION) 36 TABLE 5 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CHROMATOGRAPHY, BY COUNTRY, 2018?2030 (USD MILLION) 37 TABLE 6 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PCR, BY COUNTRY, 2018?2030 (USD MILLION) 38 TABLE 7 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR MICROSCOPY, BY COUNTRY, 2018?2030 (USD MILLION) 38 TABLE 8 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR FLOW CYTOMETRY, BY COUNTRY, 2018?2030 (USD MILLION) 39 TABLE 9 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR NEXT GENERATION SEQUENCING, BY COUNTRY, 2018?2030 (USD MILLION) 40 TABLE 10 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CENTRIFUGES, BY COUNTRY, 2018?2030 (USD MILLION) 40 TABLE 11 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR ELECTROPHORESIS, BY COUNTRY, 2018?2030 (USD MILLION) 41 TABLE 12 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CELL COUNTING, BY COUNTRY, 2018?2030 (USD MILLION) 42 TABLE 13 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CRYOGENIC INSTRUMENTS, BY COUNTRY, 2018?2030 (USD MILLION) 42 TABLE 14 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 43 TABLE 15 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 44 TABLE 16 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR RESEARCH APPLICATIONS, BY COUNTRY, 2018?2030 (USD MILLION) 45 TABLE 17 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR CLINICAL & DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2018?2030 (USD MILLION) 46 TABLE 18 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 46 TABLE 19 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 47 TABLE 20 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR HOSPITALS AND DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018?2030 (USD MILLION) 48 TABLE 21 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018?2030 (USD MILLION) 49 TABLE 22 EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, FOR OTHERS, BY COUNTRY, 2018?2030 (USD MILLION) 50 TABLE 23 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY COUNTRY, 2018?2030 (USD MILLION) 52 TABLE 24 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 53 TABLE 25 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 53 TABLE 26 EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 54 TABLE 27 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 54 TABLE 28 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 55 TABLE 29 GERMANY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 55 TABLE 30 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 56 TABLE 31 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 56 TABLE 32 FRANCE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 57 TABLE 33 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 57 TABLE 34 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 58 TABLE 35 UK: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 58 TABLE 36 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 59 TABLE 37 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 59 TABLE 38 ITALY: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 60 TABLE 39 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 60 TABLE 40 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 61 TABLE 41 SWITZERLAND: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 61 TABLE 42 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 62 TABLE 43 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 62 TABLE 44 SPAIN: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 63 TABLE 45 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY TYPE, 2018?2030 (USD MILLION) 63 TABLE 46 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY APPLICATION, 2018?2030 (USD MILLION) 64 TABLE 47 REST OF EUROPE: LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET, BY END USER, 2018?2030 (USD MILLION) 64 TABLE 48 MAJOR PLAYERS IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 65 TABLE 49 MOST ACTIVE PLAYER IN THE EUROPE LIFE SCIENCE & ANALYTICAL INSTRUMENTS MARKET 67 TABLE 50 PRODUCT LAUNCH/ PRODUCT APPROVAL 68 TABLE 51 MERGER/ACQUISITION 68 TABLE 52 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 72 TABLE 53 AGILENT TECHNOLOGIES: PRODUCTS OFFERED 76 TABLE 54 QIAGEN: PRODUCTS OFFERED 78 TABLE 55 QIAGEN: KEY DEVELOPMENTS 79 TABLE 56 PERKINELMER INC.: PRODUCTS OFFERED 81 TABLE 57 MERCK KGAA: PRODUCTS OFFERED 83 TABLE 58 MERCK KGAA: KEY DEVELOPMENTS 84 TABLE 59 EPPENDORF SE: PRODUCTS OFFERED 88 TABLE 60 BRUKER: PRODUCTS OFFERED 91 TABLE 61 BRUKER: KEY DEVELOPMENTS 92 TABLE 62 BD.: PRODUCTS OFFERED 95 TABLE 63 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 98 TABLE 64 HITACHI HIGH-TECHNOLOGIES CORPORATION: PRODUCTS OFFERED 101 ?
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Market Research Future社のライフサイエンス分野での最新刊レポート本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Market Research Future社はどのような調査会社ですか?マーケットリサーチフューチャー(Market Research Future)は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。 下記分野については、分野毎に専... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |